<SEC-DOCUMENT>0001104659-17-034636-index.html : 20170523 <SEC-HEADER>0001104659-17-034636.hdr.sgml : 20170523 <ACCEPTANCE-DATETIME>20170523170959 ACCESSION NUMBER: 0001104659-17-034636 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20170523 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20170523 DATE AS OF CHANGE: 20170523 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Nabriva Therapeutics AG CENTRAL INDEX KEY: 0001641640 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: C4 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37558 FILM NUMBER: 17864594 BUSINESS ADDRESS: STREET 1: LEBERSTRASSE 20 CITY: VIENNA STATE: C4 ZIP: 1110 BUSINESS PHONE: 43 (0)1 740 93-0 MAIL ADDRESS: STREET 1: LEBERSTRASSE 20 CITY: VIENNA STATE: C4 ZIP: 1110 </SEC-HEADER> <DOCUMENT> <TYPE>8-K <SEQUENCE>1 <FILENAME>a17-12882_38k.htm <DESCRIPTION>8-K <TEXT> Document 1 - file: a17-12882_38k.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>2 <FILENAME>a17-12882_3ex99d1.htm <DESCRIPTION>EX-99.1 <TEXT> Document 2 - file: a17-12882_3ex99d1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.2 <SEQUENCE>3 <FILENAME>a17-12882_3ex99d2.htm <DESCRIPTION>EX-99.2 <TEXT> Document 3 - file: a17-12882_3ex99d2.htm
</DOCUMENT> </SEC-DOCUMENT>